Search for: "COOK v. PFIZER, INC."
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
25 Jan 2010, 5:00 am
Cook, 1990 WL 128233, at *8 (N.D. [read post]
11 Sep 2017, 5:35 pm
").CaseBRISTOL~MYERS SQUIBB COMPANY and PFIZER INC v, Mylan ["MPI"], 2017 U.S. [read post]
27 Jul 2012, 12:40 pm
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
23 Sep 2007, 2:28 pm
Pfizer, Inc., 432 F. [read post]
12 Oct 2007, 7:03 am
Pfizer, Inc., 471 F. [read post]
3 Mar 2012, 5:36 pm
Pfizer, 196 F. [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
15 Apr 2009, 4:44 am
Cook v. [read post]
5 Jun 2013, 5:29 am
Tex. 2005) (relative risk less than 3.0 represents only a weak association) Cook v. [read post]
15 Jun 2012, 12:19 pm
Pfizer, Inc., 185 Misc. 2d 600, 607, 713 N.Y.S.2d 898 (Sup. [read post]
8 Jul 2012, 10:58 am
See Cook v. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
7 Jan 2010, 10:36 am
Wyeth, Inc., 2007 WL 2458021 (E.D. [read post]
17 Mar 2020, 1:32 pm
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
7 Jun 2007, 10:52 am
Pfizer, Inc., 198 F. [read post]
9 Mar 2010, 12:20 am
Though the justices almost never reveal their reasons for recusal, this one is almost certainly based on Roberts' stock ownership in Pfizer, which also became an issue in last year's landmark pre-emption case Wyeth v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
